David Mountcastle Sells 23,887 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 23,887 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the completion of the sale, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,327,912.27. The trade was a 12.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Privia Health Group Price Performance

Privia Health Group stock opened at $23.92 on Thursday. The stock’s 50 day moving average is $24.43 and its 200 day moving average is $22.82. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51. The firm has a market cap of $2.94 billion, a P/E ratio of 184.01, a P/E/G ratio of 4.06 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. Equities analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors and hedge funds have recently made changes to their positions in PRVA. CIBC Bancorp USA Inc. bought a new stake in Privia Health Group in the 3rd quarter valued at about $305,000. Holocene Advisors LP acquired a new stake in Privia Health Group in the third quarter valued at approximately $648,000. Focus Partners Wealth increased its holdings in shares of Privia Health Group by 108.6% during the third quarter. Focus Partners Wealth now owns 203,288 shares of the company’s stock valued at $5,060,000 after acquiring an additional 105,827 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Privia Health Group by 5.9% during the third quarter. Bank of America Corp DE now owns 1,280,284 shares of the company’s stock valued at $31,879,000 after acquiring an additional 71,060 shares in the last quarter. Finally, ArrowMark Colorado Holdings LLC acquired a new position in shares of Privia Health Group during the third quarter worth approximately $8,750,000. Institutional investors own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

PRVA has been the subject of a number of analyst reports. BMO Capital Markets started coverage on shares of Privia Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $30.00 target price for the company. Barclays increased their price target on Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Truist Financial reissued a “buy” rating and issued a $31.00 price objective (up from $30.00) on shares of Privia Health Group in a research note on Monday, November 10th. Stephens restated an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday, December 4th. Finally, JMP Securities lifted their target price on Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, August 29th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Moderate Buy” and an average target price of $30.42.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.